183 related articles for article (PubMed ID: 22878617)
1. Advanced imaging modalities in early stage breast cancer: preoperative use in the United States Medicare population.
Crivello ML; Ruth K; Sigurdson ER; Egleston BL; Evers K; Wong YN; Boraas M; Bleicher RJ
Ann Surg Oncol; 2013 Jan; 20(1):102-10. PubMed ID: 22878617
[TBL] [Abstract][Full Text] [Related]
2. Positron Emission Tomography/Magnetic Resonance Imaging for Local Tumor Staging in Patients With Primary Breast Cancer: A Comparison With Positron Emission Tomography/Computed Tomography and Magnetic Resonance Imaging.
Grueneisen J; Nagarajah J; Buchbender C; Hoffmann O; Schaarschmidt BM; Poeppel T; Forsting M; Quick HH; Umutlu L; Kinner S
Invest Radiol; 2015 Aug; 50(8):505-13. PubMed ID: 26115367
[TBL] [Abstract][Full Text] [Related]
3. A systematic review of positron emission tomography (PET) and positron emission tomography/computed tomography (PET/CT) for the diagnosis of breast cancer recurrence.
Pennant M; Takwoingi Y; Pennant L; Davenport C; Fry-Smith A; Eisinga A; Andronis L; Arvanitis T; Deeks J; Hyde C
Health Technol Assess; 2010 Oct; 14(50):1-103. PubMed ID: 21044553
[TBL] [Abstract][Full Text] [Related]
4. A National Study of the Use of Asymptomatic Systemic Imaging for Surveillance Following Breast Cancer Treatment (AFT-01).
Schumacher JR; Neuman HB; Chang GJ; Kozower BD; Edge SB; Yu M; Vanness DJ; Si Y; Jacobs EA; Francescatti AB; Spears PA; Havlena J; Adesoye T; McKellar D; Winchester D; Burnside ES; Greenberg CC;
Ann Surg Oncol; 2018 Sep; 25(9):2587-2595. PubMed ID: 29777402
[TBL] [Abstract][Full Text] [Related]
5. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
6. Use of posttreatment imaging and biomarkers in survivors of early-stage breast cancer: Inappropriate surveillance or necessary care?
Hahn EE; Tang T; Lee JS; Munoz-Plaza CE; Shen E; Rowley B; Maeda JL; Mosen DM; Ruckdeschel JC; Gould MK
Cancer; 2016 Mar; 122(6):908-16. PubMed ID: 26650715
[TBL] [Abstract][Full Text] [Related]
7. High-cost imaging in elderly patients with stage IV cancer.
Hu YY; Kwok AC; Jiang W; Taback N; Loggers ET; Ting GV; Lipsitz SR; Weeks JC; Greenberg CC
J Natl Cancer Inst; 2012 Aug; 104(15):1164-72. PubMed ID: 22851271
[TBL] [Abstract][Full Text] [Related]
8. Pure ground glass nodular adenocarcinomas: Are preoperative positron emission tomography/computed tomography and brain magnetic resonance imaging useful or necessary?
Cho H; Lee HY; Kim J; Kim HK; Choi JY; Um SW; Lee KS
J Thorac Cardiovasc Surg; 2015 Sep; 150(3):514-20. PubMed ID: 26189165
[TBL] [Abstract][Full Text] [Related]
9. Positron emission tomography and bone metastases.
Fogelman I; Cook G; Israel O; Van der Wall H
Semin Nucl Med; 2005 Apr; 35(2):135-42. PubMed ID: 15765376
[TBL] [Abstract][Full Text] [Related]
10. Quality of post-treatment surveillance of early stage breast cancer in Texas.
Parmar AD; Sheffield KM; Vargas GM; Han Y; Chao C; Riall TS
Surgery; 2013 Aug; 154(2):214-25. PubMed ID: 23889950
[TBL] [Abstract][Full Text] [Related]
11. Clinical Impact of ASCO Choosing Wisely Guidelines on Staging Imaging for Early-Stage Breast Cancers: A Time Series Analysis Using SEER-Medicare Data.
Baltz AP; Siegel ER; Kamal AH; Siegel R; Kozlik MM; Crist STS; Makhoul I;
JCO Oncol Pract; 2023 Feb; 19(2):e274-e285. PubMed ID: 36375114
[TBL] [Abstract][Full Text] [Related]
12. Pattern of Imaging after Lung Cancer Resection. 1992-2005.
Sharma G; Nishi SP; Lin YL; Kuo YF; Goodwin JS; Riall TS
Ann Am Thorac Soc; 2016 Sep; 13(9):1559-67. PubMed ID: 27243464
[TBL] [Abstract][Full Text] [Related]
13. Use of bone scan during initial prostate cancer workup, downstream procedures, and associated Medicare costs.
Falchook AD; Salloum RG; Hendrix LH; Chen RC
Int J Radiat Oncol Biol Phys; 2014 Jun; 89(2):243-8. PubMed ID: 24321784
[TBL] [Abstract][Full Text] [Related]
14. Impact of Pretreatment Combined (18)F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Staging on Radiation Therapy Treatment Decisions in Locally Advanced Breast Cancer.
Ng SP; David S; Alamgeer M; Ganju V
Int J Radiat Oncol Biol Phys; 2015 Sep; 93(1):111-7. PubMed ID: 26279029
[TBL] [Abstract][Full Text] [Related]
15. Variation in positron emission tomography use after colon cancer resection.
Bailey CE; Hu CY; You YN; Kaur H; Ernst RD; Chang GJ
J Oncol Pract; 2015 May; 11(3):e363-72. PubMed ID: 25852143
[TBL] [Abstract][Full Text] [Related]
16. The use of imaging in endometrial cancer prior to potential surgery: Are guidelines being followed?
Schnarr KL; Seow H; Elit LM; Pond GR; Helpman L; O'Leary E; Kong I
Gynecol Oncol; 2021 May; 161(2):361-366. PubMed ID: 33750604
[TBL] [Abstract][Full Text] [Related]
17. Preoperative staging of large primary breast cancer with [18F]fluorodeoxyglucose positron emission tomography/computed tomography compared with conventional imaging procedures.
Fuster D; Duch J; Paredes P; Velasco M; Muñoz M; Santamaría G; Fontanillas M; Pons F
J Clin Oncol; 2008 Oct; 26(29):4746-51. PubMed ID: 18695254
[TBL] [Abstract][Full Text] [Related]
18. Variations in use of imaging in a national sample of men with early-stage prostate cancer.
Saigal CS; Pashos CL; Henning JM; Litwin MS
Urology; 2002 Mar; 59(3):400-4. PubMed ID: 11880080
[TBL] [Abstract][Full Text] [Related]
19. Positron emission tomography (PET) and magnetic resonance imaging (MRI) for the assessment of axillary lymph node metastases in early breast cancer: systematic review and economic evaluation.
Cooper KL; Meng Y; Harnan S; Ward SE; Fitzgerald P; Papaioannou D; Wyld L; Ingram C; Wilkinson ID; Lorenz E
Health Technol Assess; 2011 Jan; 15(4):iii-iv, 1-134. PubMed ID: 21276372
[TBL] [Abstract][Full Text] [Related]
20. Coregistered whole body magnetic resonance imaging-positron emission tomography (MRI-PET) versus PET-computed tomography plus brain MRI in staging resectable lung cancer: comparisons of clinical effectiveness in a randomized trial.
Yi CA; Lee KS; Lee HY; Kim S; Kwon OJ; Kim H; Choi JY; Kim BT; Hwang HS; Shim YM
Cancer; 2013 May; 119(10):1784-91. PubMed ID: 23423920
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
